We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Swiftmerge Acquisition Corporation | NASDAQ:IVCP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.28 | 10.17 | 18.04 | 230 | 18:39:40 |
☒ | QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands |
98-1582153 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) | |
4318 Forman Ave Toluca Lake, |
91602 | |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one Class A Ordinary Share, $0.0001 par value, and one-half of one redeemable warrant |
IVCPU |
The Nasdaq Stock Market LLC | ||
Class A Ordinary Shares included as part of the units |
IVCP |
The Nasdaq Stock Market LLC | ||
Redeemable Warrants included as part of the units, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 |
IVCPW |
The Nasdaq Stock Market LLC |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Page No. |
||||||
Item 1. |
1 | |||||
1 | ||||||
2 | ||||||
3 | ||||||
4 | ||||||
5 | ||||||
Item 2. |
20 | |||||
Item 3. |
24 | |||||
Item 4. |
24 | |||||
Item 1. |
26 | |||||
Item 1A. |
26 | |||||
Item 2. |
26 | |||||
Item 3. |
27 | |||||
Item 4. |
27 | |||||
Item 5. |
27 | |||||
Item 6. |
27 | |||||
28 |
• | our ability to select an appropriate target business or businesses; |
• | our ability to complete our initial business combination; |
• | our expectations around the performance of the prospective target business or businesses; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
• | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
• | our potential ability to obtain additional financing to complete our initial business combination; |
• | our pool of prospective target businesses; |
• | our ability to consummate an initial business combination due to the uncertainty resulting from the COVID-19 pandemic and other events (such as an outbreak or escalation of armed hostilities or acts of war, terrorist attacks, natural disasters or other significant outbreaks of infectious diseases); |
• | the ability of our officers and directors to generate a number of potential business combination opportunities; |
• | our public securities’ potential liquidity and trading; |
• | the lack of a market for our securities; |
• | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; |
• | the trust account not being subject to claims of third parties; or |
• | our financial performance following our initial public offering. |
June 30, 2022 |
December 31, 2021 |
|||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash |
$ | 578,859 | $ | 875,831 | ||||
Prepaid expenses |
572,216 | 561,405 | ||||||
|
|
|
|
|||||
Total current assets |
1,151,075 |
1,437,236 |
||||||
Prepaid insurance - noncurrent |
|
|
245,040 |
|
|
|
513,628 |
|
Investments held in Trust Account |
227,573,238 | 202,000,481 | ||||||
|
|
|
|
|||||
TOTAL ASSETS |
$ |
228,969,353 |
$ |
203,951,345 |
||||
|
|
|
|
|||||
LIABILITIES AND SHAREHOLDERS’ DEFICIT |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 14,210 | $ | 33,057 | ||||
Accrued offering costs |
311,430 | 320,185 | ||||||
Due to Sponsor |
2,284 | 2,284 | ||||||
Accrued expenses |
301,462 | 79,875 | ||||||
Accrued expenses - related party |
33,000 | — | ||||||
|
|
|
|
|||||
Total current liabilities |
662,386 |
435,401 |
||||||
Deferred underwriting fee payable |
7,875,000 | 7,000,000 | ||||||
|
|
|
|
|||||
Total liabilities |
8,537,386 |
7,435,401 |
||||||
Commitments and Contingencies (Note 6) |
||||||||
Temporary Equity: Class A ordinary shares subject to possible redemption, $.0001 par value; 22,500,000 and |
227,473,238 | 202,000,000 | ||||||
Shareholders’ Deficit |
||||||||
Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding |
— | — | ||||||
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; no shares issued and outstanding (excluding 22,500,000 and 20,000,000 shares subject to possible redemption as of June 30, 2022 and December 31, 2021, respectively) |
— | — | ||||||
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,625,000 and 5,750,000 issued and outstanding as of June 30, 2022 and December 31, 2021, respectively (1) |
562 | 575 | ||||||
Additional paid-in capital |
— | — | ||||||
Accumulated deficit |
(7,041,833 | ) | (5,484,631 | ) | ||||
|
|
|
|
|||||
Total Shareholders’ Deficit |
(7,041,271 |
) |
(5,484,056 |
) | ||||
|
|
|
|
|||||
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT |
$ |
228,969,353 |
$ |
203,951,345 |
||||
|
|
|
|
(1) |
Includes up to 750,000 Class B ordinary shares subject to forfeiture as of December 31, 2021 if the Over-Allotment Option was not exercised in full or in part by the underwriter. On January 18, 2022 , in connection with the partial exercise of the underwriter’s Over-Allotment Option, the Sponsor irrevocably surrendered to the Company for cancellation and for no consideration 125,000 Class B ordinary shares resulting in 5,625,000 Class B ordinary shares outstanding (see Note 7). |
Three Months Ended June 30, 2022 |
Three Months Ended June 30, 2021 |
Six Months ended June 30, 2022 |
For the Period From February 3, 2021 (Inception) Through June 30, 2021 |
|||||||||||||
Formation and operating costs |
$ | 355,828 | $ | — | $ | 781,733 | $ | 6,728 | ||||||||
Loss from operations |
(355,828 |
) |
— |
(781,733 |
) |
(6,728 |
) | |||||||||
Loss on sale of Private Placement Warrants |
— | — | (30,000 | ) | — | |||||||||||
Gain on investments held in Trust Account |
301,214 | — | 322,756 | — | ||||||||||||
Net loss |
$ |
(54,614 |
) |
$ |
— |
$ |
(488,977 |
) |
$ |
(6,728 |
) | |||||
Basic and diluted weighted average shares outstanding, Class A ordinary shares |
22,500,000 | — | 22,251,381 | — | ||||||||||||
Basic and diluted net loss per share, Class A ordinary shares |
$ | (0.00 | ) | $ | — | $ | (0.02 | ) | $ | — | ||||||
Basic and diluted weighted average shares outstanding, Class B ordinary shares |
5,625,000 | 5,000,000 | 5,562,845 | 5,000,000 | ||||||||||||
Basic and diluted net loss per share, Class B ordinary shares |
$ | (0.00 | ) | $ | 0.00 | $ | (0.02 | ) | $ | (0.00 | ) | |||||
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance at January 1, 2022 |
— |
$ |
— |
5,750,000 |
$ |
575 |
$ |
— |
$ |
(5,484,631 |
) |
$ |
(5,484,056 |
) | ||||||||||||||
Proceeds from Initial Public Offering allocated to Public Warrants, net of offering costs |
— | — | — | — | 1,181,250 | — | 1,181,250 | |||||||||||||||||||||
Issuance of Private Placement Warrants |
— | — | — | — | 780,000 | — | 780,000 | |||||||||||||||||||||
Forfeiture of Class B Shares by Sponsor |
— | — | (125,000 | ) | (13 | ) | — | 13 | — | |||||||||||||||||||
Accretion of Class A ordinary shares to redemption amount |
— | — | — | — | (1,961,250 | ) | (845,000 | ) | (2,806,250 | ) | ||||||||||||||||||
Net loss |
— | — | — | — | — | (434,363 | ) | (434,363 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at March 31, 2022 |
— | — | 5,625,000 | 562 | — | (6,763,981 | ) | (6,763,419 | ) | |||||||||||||||||||
Accretion of Class A ordinary shares to redemption amount |
— | — | — | — | — | (223,238 | ) | (223,238 | ) | |||||||||||||||||||
Net loss |
— | — | — | — | — | (54,614 | ) | (54,614 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at June 30, 2022 |
— |
$ |
— |
5,625,000 |
$ |
562 |
$ |
— |
$ |
(7,041,833 |
) |
$ |
(7,041,271 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholder’s Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance at February 3, 2021 (inception) |
— |
$ |
— |
— |
$ |
— |
$ |
— |
$ |
— |
$ |
— |
||||||||||||||||
Issuance of Class B ordinary shares to Sponsor (1) |
— | — | 5,750,000 | 575 | 24,425 | — | 25,000 | |||||||||||||||||||||
Net loss |
— | — | — | — | — | (6,728 | ) | (6,728 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at March 31, 2021 |
— | — | 5,750,000 | 575 | 24,425 | (6,728 | ) | 18,272 | ||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at June 30, 2021 |
— |
$ |
— |
5,750,000 |
$ |
575 |
$ |
24,425 |
$ |
(6,728 |
) |
$ |
18,272 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Includes up to 750,000 Class B ordinary shares subject to forfeiture if the Over-Allotment Option is not exercised in full or in part by the underwriter (see Note 5). |
Six Months Ended June 30, 2022 |
For the period from February 3, 2021 (inception) through June 30, 2021 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net loss |
$ | (488,977 | ) | $ | (6,728 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Payment of formation and operating costs through due to related party |
— | 460 | ||||||
Payment of formation and operating costs through promissory note - related party |
— | 6,268 | ||||||
Loss on sale of Private Placement Warrants |
30,000 | — | ||||||
Gain on investments held in Trust Account |
(322,756 | ) | — | |||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
257,777 | — | ||||||
Accounts payable |
(18,848 | ) | — | |||||
Accrued expenses |
221,587 | — | ||||||
Accrued offering costs |
(8,755 | ) | — | |||||
Accrued expenses - related party |
33,000 | — | ||||||
|
|
|
|
|||||
Net cash used in operating activities |
(296,972 |
) |
— |
|||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Cash deposited in Trust Account |
(25,250,000 | ) | — | |||||
|
|
|
|
|||||
Net cash used in investing activities |
(25,250,000 |
) |
— |
|||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from Initial Public Offering, net of underwriting discount paid |
24,500,000 | — | ||||||
Proceeds from sale of Private Placement Warrants |
750,000 | — | ||||||
|
|
|
|
|||||
Net cash provided by financing activities |
25,250,000 | — | ||||||
|
|
|
|
|||||
Net Change in Cash |
(296,972 |
) |
— |
|||||
Cash - Beginning of period |
875,831 | — | ||||||
|
|
|
|
|||||
Cash - End of period |
$ |
578,859 |
$ |
— |
||||
|
|
|
|
|||||
Non-cash investing and financing activities: |
||||||||
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares |
$ | — | $ | 25,000 | ||||
|
|
|
|
|||||
Deferred offering costs included in accrued offering costs |
$ | — | $ | 636,802 | ||||
|
|
|
|
|||||
Deferred offering costs included in due to related party |
$ | — | $ | 44,675 | ||||
|
|
|
|
|||||
Accretion of Class A ordinary shares subject to redemption to redemption value |
$ | 3,029,488 | $ | — | ||||
|
|
|
|
|||||
Deferred underwriting fee payable |
$ | 875,000 | $ | — | ||||
|
|
|
|
|||||
Forfeiture of Class B ordinary shares by Sponsor |
$ | 13 | $ | — | ||||
|
|
|
|
Gross proceeds |
$ | 200,000,000 | ||
Less: |
||||
Proceeds allocated to Public Warrants |
(11,400,000 | ) | ||
Issuance costs allocated to Class A ordinary shares |
(23,558,138 | ) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
36,958,138 | |||
|
|
|||
Class A ordinary shares subject to possible redemption at December 31, 2021 |
202,000,000 |
|||
Plus: |
||||
Proceeds from over-allotment warrants |
750,000 | |||
Proceeds from over-allotment units less cash underwriting discount |
24,500,000 | |||
Accretion of carrying value to redemption value |
223,238 | |||
|
|
|||
Class A ordinary shares subject to possible redemption at June 30, 2022 |
$ |
227,473,238 |
||
|
|
Three Months Ended June 30, 2022 |
Three Months Ended June 30, 2021 |
Six Months Ended June 30, 2022 |
For the Period From February 3, 2021 (Inception) Through June 30, 2021 |
|||||||||||||||||||||||||||||
Class A |
Class B |
Class A |
Class B |
Class A |
Class B |
Class A |
Class B |
|||||||||||||||||||||||||
Basic and diluted net loss per share: |
||||||||||||||||||||||||||||||||
Numerator: |
||||||||||||||||||||||||||||||||
Net loss |
$ | (43,691 | ) | $ | (10,923 | ) | $ | — | $ | — | $ | (391,182 | ) | $ | (97,795 | ) | $ | — | $ | (6,728 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Denominator: |
||||||||||||||||||||||||||||||||
Basic and diluted weighted average shares outstanding |
22,500,000 | 5,625,000 | — | 5,000,000 | 22,251,381 | 5,562,845 | — | 5,000,000 | ||||||||||||||||||||||||
Basic and diluted net income per ordinary share |
$ | (0.00 | ) | $ | (0.00 | ) | $ | 0.00 | $ | 0.00 | $ | (0.02 | ) | $ | (0.02 | ) | $ | 0.00 | $ | (0.00 | ) |
• | at any time after the warrants become exercisable; |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; |
• | if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and |
• | if, and only if, there is a current registration statement in effect with respect to the Class A ordinary shares underlying such warrants. |
Description |
Amount at Fair Value |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
June 30, 2022 |
||||||||||||||||
Assets |
||||||||||||||||
Investments held in Trust Account: |
||||||||||||||||
U.S. Treasury Securities Money Market Funds |
$ | 227,573,238 | $ | 227,573,238 | $ | — | $ | — | ||||||||
December 31, 2021 |
||||||||||||||||
Assets |
||||||||||||||||
Investments held in Trust Account: |
||||||||||||||||
U.S. Treasury Securities Money Market Funds |
$ | 202,000,481 | $ | 202,000,481 | $ | — | $ | — |
Exhibit Number |
Description | |
101.SCH* | Inline XBRL Taxonomy Extension Schema. | |
101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase. | |
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase. | |
101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase. | |
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase. | |
104* | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
* | Filed herewith. |
** | Furnished herewith. |
(1) | Incorporated by reference to the registrant’s Current Report on Form 8-K, filed with the SEC on December 20, 2021. |
(2) | Incorporated by reference to the registrant’s Annual Report on Form 10-K, filed with the SEC on April 8, 2022. |
SWIFTMERGE ACQUISITION CORP. | ||||||||
Date: August 22, 2022 | By: | /s/ John Bremner | ||||||
Name: | John Bremner | |||||||
Title: | Chief Executive Officer |
SWIFTMERGE ACQUISITION CORP. | ||||||||
Date: August 22, 2022 | By: | /s/ Christopher J. Munyan | ||||||
Name: | Christopher J. Munyan | |||||||
Title: | Chief Financial Officer |
1 Year Swiftmerge Acquisition Chart |
1 Month Swiftmerge Acquisition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions